Abstract
Wastewater receives per- and polyfluoroalkyl substances (PFAS) from diverse consumer and industrial sources, and discharges are known to be a concern for drinking water quality. The PFAS family includes thousands of potential chemical structures containing organofluorine moieties. Exposures to a few well-studied PFAS, mainly perfluoroalkyl acids (PFAA), have been associated with increased risk of many adverse health outcomes, prompting federal drinking water regulations for six compounds in 2024. Here, we find that the six regulated PFAS (mean = 7 to 8%) and 18 measured PFAA (mean = 11 to 21%) make up only a small fraction of the extractable organofluorine (EOF) in influent and effluent from eight large municipal wastewater treatment facilities. Most of the EOF in influent (75%) and effluent (62%) consists of mono- and polyfluorinated pharmaceuticals. The treatment technology and sizes of the treatment facilities in this study are similar to those serving 70% of the US population. Despite advanced treatment technologies, the maximum EOF removal efficiency among facilities in this work was <25%. Extrapolating our measurements to other large facilities across the United States results in a nationwide EOF discharge estimate of 1.0 to 2.8 million moles F y
−1
. Using a national model that simulates connections between wastewater discharges and downstream drinking water intakes, we estimate that the sources of drinking water for up to 23 million Americans could be contaminated above regulatory thresholds by wastewater-derived PFAS alone. These results emphasize the importance of further curbing ongoing PFAS sources and additional evaluations of the fate and toxicity of fluorinated pharmaceuticals.
Topics

No keywords indexed for this article. Browse by subject →

References
60
[2]
A Never-Ending Story of Per- and Polyfluoroalkyl Substances (PFASs)?

Zhanyun Wang, Jamie C. DeWitt, Christopher P. Higgins et al.

Environmental Science & Technology 10.1021/acs.est.6b04806
[3]
E. K. Richmond , Pharmaceuticals and personal care products (PPCPs) are ecological disrupting compounds (EcoDC). Elementa (Wash. D. C.) 5, 66 (2017).
[4]
Per- and Polyfluoroalkyl Substance Toxicity and Human Health Review: Current State of Knowledge and Strategies for Informing Future Research

Suzanne E. Fenton, Alan Ducatman, Alan Boobis et al.

Environmental Toxicology and Chemistry 10.1002/etc.4890
[7]
Committee on the Assessment of Water Reuse as an Approach for Meeting Future Water Supply Needs, Water Reuse: Potential for Expanding the Nation’s Water Supply Through Reuse of Municipal Wastewater (The National Academies Press, 2012).
[13]
Pharmaceutical pollution of the world’s rivers

John L. Wilkinson, Alistair B. A. Boxall, Dana W. Kolpin et al.

Proceedings of the National Academy of Sciences 10.1073/pnas.2113947119
[17]
Fluorine mass balance analysis of PFAS in communal waters at a wastewater plant from Austria

Viktoria Müller, Andrew Kindness, Jörg Feldmann

Water Research 10.1016/j.watres.2023.120501
[19]
U.S. Environmental Protection Agency 2006 Community Water System Survey Volume 1: Overview (U.S. Environmental Protection Agency Office of Water 2009).
[20]
K. Marrese , 2022 Clean Watersheds Needs Survey Report to Congress (Environmental Protection Agency, U.S., 2024).
[25]
Contribution of Organofluorine Compounds to Pharmaceuticals

Munenori Inoue, Yuji Sumii, Norio Shibata

ACS Omega 10.1021/acsomega.0c00830
[26]
Current Contributions of Organofluorine Compounds to the Agrochemical Industry

Yuta Ogawa, Etsuko Tokunaga, Osamu Kobayashi et al.

iScience 10.1016/j.isci.2020.101467
[27]
DrugBank 5.0: a major update to the DrugBank database for 2018

David S Wishart, Yannick D Feunang, An C Guo et al.

Nucleic Acids Research 10.1093/nar/gkx1037
[28]
Agency for Healthcare Research and Quality Medical expenditure panel survey (MEPS) 2013-2020 ClinCalc DrugStates Database version 2022.08. (2023). https://clincalc.com/DrugStats/. Accessed 1 November 2023.
[30]
J. A. Shoemaker D. R. Tettenhorst Method 537.1 determination of selected per- and polyfluorinated alkyl substances in drinking water by solid phase extraction and liquid chromatography/tandem mass spectrometry (LC/MS/MS). (2018). https://cfpub.epa.gov/si/si_public_record_Report.cfm?dirEntryId=343042&Lab=NERL. Accessed 3 November 2023.
[31]
L. Rosenblum S. C. Wendelken Method 533: Determination of per- and polyfluoroalkyl substances in drinking water by isotope dilution anion exchange solid phase extraction and liquid chromatography/tandem mass spectrometry. (2019). https://www.epa.gov/sites/default/files/2019-12/documents/method-533-815b19020.pdf. Accessed 3 November 2023.
[39]
U.S. Environmental Protection Agency Part 141 - National Primary Drinking Water Regulations (Federal Register 141:373–637). Regulations.gov (2023). https://www.regulations.gov/document/EPA-HQ-OW-2022-0114-0027. Accessed 27 June 2023.
[44]
Climate Change and Drought: From Past to Future

Benjamin I. Cook, Justin S. Mankin, Kevin J. Anchukaitis

Current Climate Change Reports 10.1007/s40641-018-0093-2
[46]
EUR-Lex - L:2020:435:TOC - EN - EUR-Lex. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=OJ%3AL%3A2020%3A435%3ATOC. Accessed 17 January 2024.
[50]
R. Fox Addressing PFAS Discharges in NPDES permits and through the pretreatment program and monitoring programs. (2022). https://www.epa.gov/system/files/documents/2022-12/NPDES_PFAS_State%20Memo_December_2022.pdf. Accessed 17 November 2023.

Showing 50 of 60 references

Metrics
32
Citations
60
References
Details
Published
Jan 06, 2025
Vol/Issue
122(3)
License
View
Funding
Water Research Foundation Award: Project 5031
Cite This Article
Bridger J. Ruyle, Emily H. Pennoyer, Simon Vojta, et al. (2025). High organofluorine concentrations in municipal wastewater affect downstream drinking water supplies for millions of Americans. Proceedings of the National Academy of Sciences, 122(3). https://doi.org/10.1073/pnas.2417156122